Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries

Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries

Background: Rising expenditure for new cancer medicines is accelerating concerns that their costs will become unsustainable for universal healthcare access. Moreover, early market access of new oncology medicines lacking appropriate clinical evaluation generates uncertainty over their cost-effective...

Full description

Bibliographic Details
Main Authors:	Alice Pisana, Björn Wettermark, Amanj Kurdi, Biljana Tubic, Caridad Pontes, Corinne Zara, Eric Van Ganse, Guenka Petrova, Ileana Mardare, Jurij Fürst, Marta Roig-Izquierdo, Oyvind Melien, Patricia Vella Bonanno, Rita Banzi, Vanda Marković-Peković, Zornitsa Mitkova, Brian Godman
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Pharmacology
Subjects:	new cancer medicines patient-level datasets pricing and reimbursement funding concerns pharmaceutical policy cross-national collaboration
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.873556/full

Similar Items

Managing infectious diarrhea among young children in community pharmacies in Saudi Arabia and the implications for AMR
by: Faris S. Alnezary, et al.
Published: (2024-03-01)

Clinical and Financial Implications of Medicine Consumption Patterns at a Leading Referral Hospital in Kenya to Guide Future Planning of Care
by: Patrick M. Kivoto, et al.
Published: (2018-12-01)

A systematic review and meta‐analysis of the use of renin‐angiotensin system drugs and COVID‐19 clinical outcomes: What is the evidence so far?
by: Amanj Kurdi, et al.
Published: (2020-12-01)

Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications
by: Ljubica Bojanić, et al.
Published: (2018-05-01)

A Review of the Evidence on Attitudes, Perceived Impacts and Motivational Factors for European Member State Collaboration for Pricing and Reimbursement of Medicines: Time for the EEA Member States to Apply Their Experience and Expertise in Evidence-Based Decision Making to Their Current Pharmaceutical Policy Challenges
by: Patricia Vella Bonanno, et al.
Published: (2021-11-01)

Opioids and Gabapentinoids Utilisation and Their Related-Mortality Trends in the United Kingdom Primary Care Setting, 2010–2019: A Cross-National, Population-Based Comparison Study
by: Amanj Kurdi, et al.
Published: (2021-09-01)

Estimated indirect costs of haemodialysis versus peritoneal dialysis from a patients’ perspective at an Academic Hospital in Pretoria, South Africa
by: Kotulo Moalosi, et al.
Published: (2023-10-01)

Utilisation, Availability and Price Changes of Medicines and Protection Equipment for COVID-19 Among Selected Regions in India: Findings and Implications
by: Mainul Haque, et al.
Published: (2021-01-01)

Antimicrobial Stewardship Activities in Public Healthcare Facilities in South Africa: A Baseline for Future Direction
by: Deirdré Engler, et al.
Published: (2021-08-01)

Perceptions of and Preparedness for the Application of Pharmacoeconomics in Practice, among Final Year Bachelor of Pharmacy Students in South Africa: A National Cross-Sectional Study
by: Carlien Schmidt, et al.
Published: (2023-03-01)

Development and Validation of a Tool to Improve Community Pharmacists’ Surveillance Role in the Safe Dispensing of Herbal Supplements
by: Ammar Abdulrahman Jairoun, et al.
Published: (2022-07-01)

Audit of antibiotic utilization patterns and practice for common eye infections at the ambulatory clinic of a teaching hospital in Ghana: Findings and implications.
by: Israel Abebrese Sefah, et al.
Published: (2024-01-01)

Antibiotic prescribing patterns at a leading referral hospital in Kenya: A point prevalence survey
by: Lydia Momanyi, et al.
Published: (2019-01-01)

Correction: Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis.
by: Faisal Salman Alshaikh, et al.
Published: (2024-01-01)

Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis.
by: Faisal Salman Alshaikh, et al.
Published: (2022-01-01)

Patients' knowledge and practice on disposal of medicines kept in households in South Africa: Findings and implications
by: Kesentseng Jackson Mahlaba, et al.
Published: (2022-01-01)

Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis
by: Faisal Salman Alshaikh, et al.
Published: (2022-01-01)

Prevalence rate of spontaneously reported adverse events and determinants of serious adverse events amongst three outpatient care settings in ghana: findings and implications
by: Israel Abebrese Sefah, et al.
Published: (2021-01-01)

Health-Care professionals' knowledge and practice regarding disposal of medicines in primary health-care facilities in South Africa: Impact and implications
by: Kesentseng Jackson Mahlaba, et al.
Published: (2021-01-01)

Comparison of Zidovudine and Tenofovir Based Regimens With Regard to Health-Related Quality of Life and Prevalence of Symptoms in HIV Patients in a Kenyan Referral Hospital
by: Jilian O. Etenyi, et al.
Published: (2018-10-01)

Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets
by: Brian Godman, et al.
Published: (2018-12-01)

Impact of Parental Knowledge and Beliefs on HPV Vaccine Hesitancy in Kenya—Findings and Implications
by: Chester O. Kolek, et al.
Published: (2022-07-01)

Changes in availability, utilization, and prices of medicines and protection equipment for COVID-19 in an Urban population of Northern Nigeria
by: Mainul Haque, et al.
Published: (2021-01-01)

Antibiotic consumption and antimicrobial resistance in Poland; findings and implications
by: Jadwiga Wojkowska-Mach, et al.
Published: (2018-11-01)

Risk Awareness and Demographic Characteristics Associated With the Use of Sexual Enhancement Supplements Among University Staff: A Cross-Sectional Study in the United Arab Emirates
by: Ammar Abdulrahman Jairoun, et al.
Published: (2023-03-01)

Switching Among Biosimilars: A Review of Clinical Evidence
by: Eleonora Allocati, et al.
Published: (2022-08-01)

Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future
by: Brian Godman, et al.
Published: (2020-12-01)

Frequency and determinants of domestic violence against Iranian women during the COVID-19 pandemic: a national cross-sectional survey
by: Arezoo Yari, et al.
Published: (2021-09-01)

Editorial: Pharmaceutical policy, impact and health outcomes
by: Hye-Young Kwon, et al.
Published: (2023-02-01)

The prevalence of medication errors among nursing students: A systematic and meta-analysis study
by: Fazel Dehvan, et al.
Published: (2021-01-01)

Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications
by: Israel Abebrese Sefah, et al.
Published: (2021-01-01)

Availability and Affordability of Drugs With a Conditional Approval by the European Medicines Agency; Comparison of Korea With Other Countries and the Implications
by: Hye-Young Kwon, et al.
Published: (2018-09-01)

Availability and accessibility of monoclonal antibodies in Bosnia and Herzegovina: Findings and implications
by: Biljana Tubic, et al.
Published: (2021-07-01)

Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions
by: Mohamed Gad, et al.
Published: (2020-03-01)

Evidence for the involvement of G<sub>i2</sub> in activation of extracellular signal-regulated kinases in hepatocytes
by: Sioud Mouldy, et al.
Published: (2001-07-01)

Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation
by: Patricia Vella Bonanno, et al.
Published: (2017-08-01)

Ongoing initiatives to improve the prescribing of medicines across sectors and the implications
by: Brian Godman
Published: (2020-01-01)

Health authority activities to enhance the quality and efficiency of medicine use and their impact
by: Brian Godman
Published: (2021-01-01)

Prevalence of depression among Iranian patients under hemodialysis: a systematic review and meta-analysis
by: Alireza Abdi, et al.
Published: (2018-10-01)

COVID-19, health care and self-medication issues in resource-limited settings: Findings and implications based on experiences in Ghana
by: Israel Abebrese Sefah, et al.
Published: (2021-01-01)